Sorafenib: Multikinase Inhibitor Advancing Cancer Biology...
2026-01-19
Sorafenib (BAY-43-9006) is a powerful multikinase inhibitor that has redefined experimental workflows in cancer biology, enabling precise interrogation of Raf/MEK/ERK and VEGFR-2 signaling. This in-depth guide details protocols, advanced applications, and troubleshooting strategies, empowering researchers to harness Sorafenib for antiangiogenic and antiproliferative studies across diverse tumor models.